Quantum Genesis AI Corp. (OTCPK: QGAI)
Health Care · Biotechnology · US
$0.07
-49.60% today · -62.2% 1Y
Quantum Genesis AI Corp. (OTCPK: QGAI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.87M.
Over the last twelve months the share price has lost 62.2%, trading between 0.00 and 5.04.
Tweenvest scores Quantum Genesis AI Corp. across four factors: quality 0/100, value 78/100. Its strongest factor is value.
QGAI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.87M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- 9.84
- 52-week high
- $5.04
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 40.97M
- Employees
- —
- Next earnings
- —
About Quantum Genesis AI Corp.
Quantumzyme Corp. operates as a biotransformation company. It develops engineered enzymes for use in active pharmaceutical ingredients production. The company was formerly known as Reliant Services, Inc. and changed its name to Quantumzyme Corp. in March 2023. The company was incorporated in 2015 and is based in San Diego, California.
- ISIN
- US75955E2054
- Founded
- 2015
- Listed since
- Nov 20, 2024
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Quest PharmaTech Inc.TSXV: QPT | $2.99M | CA$0.02 | -20.00% |
| VivoSim Labs, Inc.NasdaqCM: VIVS | $2.92M | $0.18 | -9.22% |
| GeoVax Labs, Inc.NasdaqCM: GOVX | $2.91M | $0.27 | -14.78% |
| Onconetix, Inc.NasdaqCM: ONCO | $2.90M | $0.64 | -13.32% |
| BSF Enterprise PlcLSE: BSFA | $2.86M | £0.01 | -2.22% |
| Bioxytran, Inc.OTCPK: BIXT | $2.74M | $0.02 | +13.27% |
| BioRestorative Therapies, Inc.NasdaqCM: BRTX | $2.73M | $1.88 | -12.15% |
| Vaccinex, Inc.OTCPK: VCNX | $2.70M | $1.01 | +4.12% |
Figures last refreshed Oct 4, 2026.